Signet Industries [SIGIND] vs Chemo-Pharma [CPL] Detailed Stock Comparison

Signet Industries Ltd.

NSE
Loading...

Chemo-Pharma Laboratories Inc.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Signet Industries Ltd. wins in 9 metrics, Chemo-Pharma Laboratories Inc. wins in 10 metrics, with 0 ties. Chemo-Pharma Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Signet Industries Ltd. Chemo-Pharma Laboratories Inc. Better
P/E Ratio (TTM) 8.95 13.22 Signet Industries Ltd.
Price-to-Book Ratio 0.69 2.69 Signet Industries Ltd.
Debt-to-Equity Ratio 173.84 48.02 Chemo-Pharma Laboratories Inc.
PEG Ratio 0.57 0.42 Chemo-Pharma Laboratories Inc.
EV/EBITDA 5.58 13.60 Signet Industries Ltd.
Profit Margin (TTM) 1.27% 6.53% Chemo-Pharma Laboratories Inc.
Operating Margin (TTM) 5.66% 11.52% Chemo-Pharma Laboratories Inc.
EBITDA Margin (TTM) 5.66% 11.52% Chemo-Pharma Laboratories Inc.
Return on Equity 6.53% 20.97% Chemo-Pharma Laboratories Inc.
Return on Assets (TTM) 1.80% 11.26% Chemo-Pharma Laboratories Inc.
Free Cash Flow (TTM) $117.80M $41.66M Signet Industries Ltd.
Dividend Yield 0.89% N/A N/A
1-Year Return -25.15% -5.34% Chemo-Pharma Laboratories Inc.
Price-to-Sales Ratio (TTM) 0.11 1.31 Signet Industries Ltd.
Enterprise Value $5.64B $5.40B Signet Industries Ltd.
EV/Revenue Ratio 0.43 1.52 Signet Industries Ltd.
Gross Profit Margin (TTM) 12.86% 24.93% Chemo-Pharma Laboratories Inc.
Revenue per Share (TTM) $451 $62 Signet Industries Ltd.
Earnings per Share (Diluted) $5.56 $5.81 Chemo-Pharma Laboratories Inc.
Beta (Stock Volatility) 0.08 0.28 Signet Industries Ltd.

Signet Industries Ltd. vs Chemo-Pharma Laboratories Inc. Stock Performance Analysis

Loading Price Chart...

SIGIND
CPL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Signet Industries Ltd.5.80%2.76%0.81%12.09%-9.49%-8.88%
Chemo-Pharma Laboratories Inc.0.43%-0.20%-9.72%10.04%-11.06%-12.31%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Signet Industries Ltd.-25.15%-14.63%1.12%-78.15%80.20%80.20%
Chemo-Pharma Laboratories Inc.-5.34%232.23%82.57%325.71%1,271.09%1,271.09%

Performance & Financial Health Analysis: Signet Industries Ltd. vs Chemo-Pharma Laboratories Inc.

MetricSIGINDCPL
Market Information
Market Cap i₹1.47B₹4.62B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i78,43597,700
90 Day Avg. Volume i45,58768,661
Last Close₹49.59₹70.50
52 Week Range₹40.66 - ₹66.89₹52.67 - ₹87.75
% from 52W High-25.86%-19.66%
All-Time High₹745.00 (Jan 25, 2016)₹128.00 (Jan 06, 2025)
% from All-Time High-93.34%-44.92%
Growth Metrics
Quarterly Revenue Growth0.28%0.40%
Quarterly Earnings Growth0.14%0.41%
Financial Health
Profit Margin (TTM) i0.01%0.07%
Operating Margin (TTM) i0.06%0.12%
Return on Equity (TTM) i0.07%0.21%
Debt to Equity (MRQ) i173.8448.02
Cash & Liquidity
Book Value per Share (MRQ)₹71.60₹28.58
Cash per Share (MRQ)₹4.64₹0.05
Operating Cash Flow (TTM) i₹-10,210,000₹277.99M
Levered Free Cash Flow (TTM) i₹152.72M₹313.23M
Dividends
Last 12-Month Dividend Yield i0.89%N/A
Last 12-Month Dividend i₹0.50₹0.00

Valuation & Enterprise Metrics Analysis: Signet Industries Ltd. vs Chemo-Pharma Laboratories Inc.

MetricSIGIND (Apr 24, 2026)CPL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i8.9513.22
Forward P/E iN/AN/A
PEG Ratio i0.570.42
Price to Sales (TTM) i0.111.31
Price to Book (MRQ) i0.692.69
Market Capitalization
Market Capitalization i₹1.47B₹4.62B
Enterprise Value i₹5.64B₹5.40B
Enterprise Value Metrics
Enterprise to Revenue i0.431.52
Enterprise to EBITDA i5.5813.60
Risk & Other Metrics
Beta i0.080.28
Book Value per Share (MRQ) i₹71.60₹28.58

Financial Statements Comparison: Signet Industries Ltd. vs Chemo-Pharma Laboratories Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSIGIND (2025)CPL (2025)
Revenue/Sales i11.79B2.85B
Cost of Goods Sold i10.02B2.07B
COGS % of Revenue i85.0%72.6%
Gross Profit i1.77B778.98M
Gross Margin i15.0%27.4%
Research & Development iN/AN/A
Operating Income (EBIT) i785.92M300.69M
Operating Margin i6.7%10.6%
EBITDA i852.06M353.29M
EBITDA Margin i7.2%12.4%
Pre-Tax Income i222.57M392.47M
Pre-Tax Income % of Revenue i1.9%13.8%
Income Tax i66.16M79.24M
Income Tax % of Revenue i0.6%2.8%
Net Income (Profit) i156.42M313.23M
Profit Margin i1.3%11.0%

Balance Sheet & Liquidity Metrics

MetricSIGIND (2025)CPL (2025)
Cash & Equivalents i11.06M12.05M
Total Current Assets i7.55B2.51B
Total Current Assets % of Revenue i64.0%88.1%
Total Current Liabilities i5.70B1.17B
Total Current Liabilities % of Revenue i48.3%41.2%
Long-Term Debt i157.54M109.50M
Long-Term Debt % of Revenue i1.3%3.8%
Total Shareholders Equity i2.34B1.49B
Retained Earnings i1.64B1.08B
Retained Earnings % of Revenue i13.9%37.9%
Property, Plant & Equipment i723.08M48.61M

Cash Flow Statement Comparison

MetricSIGIND (2025)CPL (2025)
Operating Cash Flow i-10.21M277.99M
Operating Cash Flow % of Revenue i-0.1%9.8%
Capital Expenditures i-39.14M-47.82M
Free Cash Flow i117.80M41.66M
FCF Margin i1.0%1.5%
Debt Repayment i-116.46M-359.80M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSIGINDCPL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i29.44M60.18M
Float Shares i8.30M17.41M
% Held by Insiders i67.42%69.98%
% Held by Institutions i0.00%0.00%
% Held by Public i32.58%30.02%

Dividend Analysis & Yield Comparison: Signet Industries Ltd. vs Chemo-Pharma Laboratories Inc.

MetricSIGINDCPL
Last 12-Month Dividend i₹0.50₹0.00
Last 12-Month Dividend Yield i0.89%N/A
3-Year Avg Annual Dividend i₹0.50₹0.00
3-Year Avg Dividend Yield i0.80%N/A
3-Year Total Dividends i₹1.50₹0.00
Ex-Dividend DateSep 23, 2025N/A